Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Resverlogix presentation at European Meeting on Complement in Human Disease meeting
"The share price shot up considerably post the Rodman and Renshaw presentation this time last year, from about $1.25 to the $2 range."
R&R had minimal impact on the share price last year. The share price was consistently going up starting about a month prior to R&R, which was on 9/13/16. The day before R&R (9/12/16) it closed at $1.86. Over the next few days, it crept up to ~$2 before starting its gradual drop over the next 4 months to ~$1.
